Association Between State Medicaid Policies and Accrual of Black or Hispanic Patients to Cancer Clinical Trials.
William L SchperoSamuel U TakvorianDaniel BlicksteinAfrah ShafquatJingshu LiuArnaub K ChatterjeeElizabeth B LamontPaula ChatterjeePublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Medicaid expansion was not associated with a significant increase in the proportion of Black or Hispanic oncology trial participants overall, but was associated with an increase specifically in states that mandated Medicaid coverage of the routine costs of trial participation.
Keyphrases
- clinical trial
- affordable care act
- health insurance
- phase iii
- end stage renal disease
- phase ii
- study protocol
- ejection fraction
- newly diagnosed
- chronic kidney disease
- public health
- prognostic factors
- african american
- palliative care
- peritoneal dialysis
- physical activity
- randomized controlled trial
- healthcare
- open label
- squamous cell carcinoma
- patient reported outcomes
- squamous cell
- young adults
- lymph node metastasis